Explore the institutions, biotech companies, advocacy groups, and researchers driving psychedelic science forward — from early discovery through to regulatory approval.
The enablers and multipliers — law firms, health economists, tech platforms, consultancies, and creative agencies supporting the psychedelic ecosystem.
From protocol to patient — the clinics, practitioners, retreat centres, and facilitation models delivering psychedelic-assisted experiences.
The grassroots heartbeat of the psychedelic movement — wisdom keepers, activist networks, local collectives, and organisations safeguarding cultural heritage.
The financial infrastructure powering psychedelic research — from angel investors and venture capital to philanthropic foundations and government grants.
The regulatory, legislative, and advocacy forces shaping how psychedelics move from controlled substances to approved medicines and legal frameworks.
Story, signal, and safety — the platforms educating the public, the media channels shaping the narrative, and the harm-reduction services keeping people safe.
The pathway from molecule to medicine — spanning academic labs, biotech pipelines, and the manufacturers turning compounds into pharmaceutical-grade products.
Building the human capital needed for psychedelic-assisted therapy — from university degree programmes to experiential training and professional credentialing.
Featured
Explore the global map of academic centres, clinical labs, and institutions pioneering psychedelic therapies — with interactive continent and country groupings.
Featured
Browse a source-backed country map of organizations that directly provide or enable access to ibogaine care.